Key Biologics and Astarte Biologics, providers of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry, are rebranding to Cellero. The new Cellero brand better reflects the full capabilities of the organization, which serves customers across the entire cell and gene therapy lifecycle—from concept to cure.    In 2018, Key Biologics and Astarte Biologics merged to establish a comprehensive product and service offering that provides...